India Glycols Limited has officially declared an interim dividend of ₹7.5 per equity share for the financial year 2025-26, following the conclusion of its board meeting on March 17, 2026. The company has fixed Monday, March 23, 2026 as the record date for determining shareholder eligibility for the interim dividend payment.

Board Meeting Outcome and Dividend Declaration

The board meeting, conducted pursuant to Regulation 30 and Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, commenced at 15:33 hours and concluded at 15:48 hours. The interim dividend represents 150% of the face value of ₹5 per equity share.

Shareholder Eligibility and Payment Timeline

The interim dividend will be paid within 30 days from the date of declaration to shareholders whose names appear in the Register of Members of the Company or in the records of the Depositories as beneficial owners as on the record date. This follows the company's earlier notification dated March 10, 2026, regarding the board meeting schedule.

Regulatory Compliance and Communication

The announcement was communicated to both BSE Limited and National Stock Exchange of India Limited through reference number IGL/SE/2025-26/90 dated March 17, 2026. The communication was signed by Ankur Jain, Head (Legal) & Company Secretary, and has been hosted on the company's official website at www.indiaglycols.com for stakeholder reference.

India Glycols Limited announced receiving interim dividend from its joint venture Clariant IGL Specialty Chemical Private Limited on March 17, 2026. The company disclosed this development under Regulation 30 of SEBI Listing Regulations as a material business update.

Joint Venture Dividend Declaration

Clariant IGL Specialty Chemical Private Limited declared an interim dividend of ₹36,000 per equity share of face value ₹10 each. This represents a dividend rate of 3600%, indicating substantial profitability of the joint venture operations.

Shareholding Structure and Dividend Receipt

India Glycols holds a combined 49% shareholding in the joint venture through two entities. The company directly owns 45.37% stake, while its wholly owned subsidiary holds the remaining 3.63% shareholding.

Financial Impact

The interim dividend receipt represents a significant cash inflow for India Glycols Limited. The company received ₹32.40 crore net of tax deducted at source, while the gross amount stood at ₹36 crore. Similarly, the wholly owned subsidiary received ₹2.59 crore net from a gross dividend of ₹2.88 crore.

This dividend distribution from the joint venture reflects the strong operational performance of Clariant IGL Specialty Chemical Private Limited and provides additional liquidity to India Glycols Limited for its business operations and growth initiatives.